Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Evogene Ltd. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 4.67M | 4.39M | −272.7K (−5.8%) |
| Value | $2.73M | $3.69M | +$954.8K (+34.9%) |
New holders (2)
Institutions that held Evogene Ltd. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 100,000 | $84.0K | 0.07% |
| Susquehanna International Group, LLP | 24,330 | $20.4K | 0.00% |
Sold out (4)
Institutions that held Evogene Ltd. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CVI Holdings, LLC | 261,636 | $153.2K |
| HRT Financial LP | 15,206 | $8.00K |
| Commonwealth Equity Services, LLC | 11,355 | $7.00K |
| Virtu Financial LLC | 11,605 | $7.00K |